Peterson Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Peterson Financial Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Aug 27, 2024	BUY	$68.48 - $81.09 $756,498 - $895,801	11,047 New	11,047 $795 Million
Q3 2022 Aug 26, 2024	BUY	$0.13 - $76.84 $43 - $25,818	336 Added 2.03%	16,851 $1.2 Billion
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $11 - $7,069	92 Added 0.54%	17,235 $1.23 Million
Q2 2022 Aug 26, 2024	BUY	$72.62 - $79.98 $1.2 Million - $1.32 Million	16,515 New	16,515 $1.27 Billion
Q2 2022 Jul 20, 2022	BUY	$72.62 - $79.98 $71,022 - $78,220	978 Added 6.05%	17,143 $1.32 Million
Q1 2022 Aug 26, 2024	BUY	$61.48 - $73.72 $961,485 - $1.15 Million	15,639 New	15,639 $1.14 Billion
Q1 2022 Jul 19, 2022	BUY	$61.48 - $73.72 $184 - $221	3 Added 0.02%	16,165 $1.18 Million
Q1 2022 Apr 18, 2022	SELL	$61.48 - $73.72 $1.84 Million - $2.2 Million	-29,867 Reduced 64.89%	16,162 $1.18 Million
Q4 2021 Aug 22, 2024	BUY	$53.63 - $62.52 $794,367 - $926,046	14,812 New	14,812 $924 Million
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $2.47 Million - $2.88 Million	46,029 New	46,029 $2.87 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Peterson Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Peterson Financial Group, Inc. with notifications on news.